In Europe, biosimilar medicines have captured 7% more of the biologics market over a 5-year period

Biosimilar medicines are available in therapy areas which… 16 December 2020
Ready in a crisis: Medicines for Europe commits at one year… 8 December 2022 Medicines for Europe members are major suppliers of medicines for…
Baton passes from Christoph Stoller to Rebecca Guntern as… 1 October 2021 Rebecca Guntern (Sandoz) today begins an interim term as President…
EU pharmaceutical legislation reform critical to sustain… 6 October 2022 The EU plans to update its 20-year-old pharmaceutical legislation early…